VentX Gene Modulation for Macrophage Differentiation Control

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The role of VentX in human primary monocyte to macrophage terminal differentiation and its involvement in inflammatory responses remains poorly understood, limiting therapeutic and diagnostic applications.

Innovation Solution

VentX is identified as essential for optimal pro-inflammatory responses during macrophage classical activation, with methods involving modulating its expression using biological or chemical agents to treat inflammatory diseases, and a pharmaceutical composition comprising agents that affect VentX expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If VentX expression is modulated to promote macrophage differentiation, then macrophage terminal differentiation and pro-inflammatory response is improved, but understanding and control of the differentiation process becomes more complex

Engineering Contradiction:

Improvemacrophage terminal differentiationVSAvoiddifferentiation control mechanism

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs feedback mechanisms by identifying VentX as a key regulator that responds to differentiation signals and in turn controls the expression of differentiation markers. This creates a self-regulating system where VentX expression levels feedback to control the differentiation process, improving reliability while maintaining natural physiological control

Inventive Principle:

Principle #23Feedback

Solution Approach 2:

The patent utilizes parameter changes by modulating VentX expression levels through various stimuli (cytokines, growth factors) to control macrophage differentiation. By changing the expression parameter of VentX, the system achieves reliable differentiation control without requiring complex external intervention mechanisms

Inventive Principle:

Principle #35Parameter changes

2Reliability

If VentX is used as a therapeutic target for inflammatory diseases, then treatment effectiveness is improved, but identification and development of modulating agents becomes more difficult

Engineering Contradiction:

Improvetherapeutic effectivenessVSAvoidagent identification

Core Design Contradiction:

ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent uses VentX as an intermediary target between inflammatory stimuli and macrophage activation. By identifying VentX as a mediator in the signaling pathway, the patent provides a tractable therapeutic target that can be modulated by various agents, improving treatment effectiveness while facilitating agent discovery through its central role in the pathway

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces direct manipulation of complex inflammatory pathways with modulation of VentX expression, a more manageable biological parameter. This substitution simplifies the therapeutic approach by focusing on a single key regulator rather than attempting to control multiple downstream effectors simultaneously

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS10066272B2Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof

Publication Date: 2018.09.04 ZHU ZHENGLUN

AI summary

The invention generally relates to human biology discoveries and therapeutic and diagnostic compositions and methods based thereon. More particularly, the invention relates to human homeobox gene VentX and its control of macrophage terminal differentiation and activation, and related therapeutic and diagnostic compositions and methods of use, in particular in connection with inflammatory diseases.